Philadelphia, 17 - 18 September 2024

Schedule

Create your personal agenda –check the favourite icon

Sep 178:50
Conference pass

Introductory remarks

Keynotes
Anna Abiola, Producer, Terrapinn Holdings Ltd
Sep 178:55
Conference pass

Chair remarks

Keynotes
Ziv BarJoseph, Head, R&D Data and Computational Sciences, Sanofi
Sep 179:00
Conference pass

Keynote presentation

Keynotes
Hal Stern, VP & CIO, Pharmaceutical R&D, Janssen
Sep 1710:00
Conference pass

Unlocking Future Innovation: Harnessing Data Analytics and Digital Technology as the Cornerstones

Keynotes
Moderator: Victoria Gamerman, Head of Digital Transformation Center of Excellence, Boehringer Ingelheim
Sep 1711:40
Conference pass

Chair remarks

AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1711:40
Conference pass

Chair remarks

Digital Transformation
Bronwyn Harris, Chief Transformation Officer, CareEvolution
Sep 1711:40
Conference pass

Chair remarks

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1711:40
Conference pass

Chair remarks

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:40
Conference pass

Chair remarks

Bioinformatics + In Silico R&D
Sep 1711:40
Conference pass

Chair remarks

Real World Evidence
Solomon Makgoeng, Director, Department of Epidemiology, Pfizer
Sep 1711:40
Conference pass

Chair remarks

Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1711:40
Conference pass

Chair remarks

Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1711:40
Conference pass

Chair remarks

Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1711:45
Conference pass

Data driven drug discovery: The AbbVie perspective

AI in Drug Discovery and Development
Abhishek Pandey, Global Lead and Principal Research Scientist, Abbvie
Sep 1711:45
Conference pass

Establishing a Value Framework for building GenAI capabilities

Large Language Models
Alex Villalobos, Operations Excellence and Digital Lead, Boehringer Ingelheim
Sep 1711:45
Conference pass

Sponsored presentation

Digital Transformation
Bronwyn Harris, Chief Transformation Officer, CareEvolution
Sep 1711:45
Conference pass

Mining petabytes of proteomics data for cancer diagnostics and therapeutics

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1711:45
Conference pass

The Scope of Fair Data

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass

Biological Data Science to Drive Drug Discovery: Case Studies

Bioinformatics + In Silico R&D
Joseph Szustakowski, Vice President, Translational Bioinformatics, Bristol-Myers Squibb
Sep 1711:45
Conference pass

Optimizing Data Management for Histology and Cellular Imaging Research: Challenges and Opportunities

Data Management, Storage and Architecture
Nevin Gerek Ince, Director, Novo Nordisk
Sep 1711:45
Conference pass

AI Impact on Epidemiology Practice in Pharmaceutical R&D

Real World Evidence
Solomon Makgoeng, Director, Department of Epidemiology, Pfizer
Sep 1711:45
Conference pass

In vivo correction of human phenylketonuria variants via prime editing and base editing

Gene Therapy
Xiao Wang, Research Assistant Professor, Univeristy Of Pennsylvania
Sep 1711:45
Conference pass

Biomarker Capture and Analysis for Diagnosis and Therapeutic Intervention

Biomarkers and Companion Diagnostics
Vaibhav Saini, Sr. Commercialization Manager, Northeastern University
Sep 1712:05
Conference pass

Genomic work flow service for Takeda

Gene Therapy
Justin Ducote, Head, Advanced Analytics R&D, Takeda
Sep 1712:05
Conference pass

Epigenetics: A gateway to understanding tumor heterogeneity and therapeutic response

Biomarkers and Companion Diagnostics
Johnathan R. Whetstine, Professor Jack Schultz Basic Science Endowed Chair Director, Cancer Epigenetics Institute Program Co-leader Nuclear Dynamics and, Fox Chase Cancer Center
Sep 1712:25
Conference pass

Digital Twins in Drug Discovery and Development

AI in Drug Discovery and Development
Tiffany Fabianac, Enterprise Data and AI Engagement Lead, AstraZeneca
Sep 1712:25
Conference pass
Sep 1712:25
Conference pass

Shaping the regulatory function to support product digital transformation

Digital Transformation
David Morra, Director, Regulatory Digital Health, Merck
Sep 1712:25
Conference pass

Implementation of real world multi-model data in oncology discovery and development

Big Data in Oncology
Sunita Badola, Head, Oncology Data Strategy & Partnerships, Takeda Pharmaceuticals
Sep 1712:25
Conference pass

What is FAIR in Data Integration

Data Integration + FAIR
Alexander Sherman, Director, Center for innovation and Bioinformatics Neurological Clinical Research, Massachusetts General Hospital
Sep 1712:25
Conference pass

Preparing for pervasive AI – ontologies, data lakes and governance

Bioinformatics + In Silico R&D
Sep 1712:25
Conference pass

Real world evidence on digital health in diabetes

Real World Evidence
Felix Lee, US Digital Healthcare Medical Head, Sanofi
Sep 1712:25
Conference pass

Reinventing Clinical Trial Models: Promises and Challenges

Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1712:25
Conference pass

Companion Diagnostics - start with the end in mind

Biomarkers and Companion Diagnostics
Lee-anne Zinetti, Senior Director, Global Lead Precision Medicine, Novartis
Sep 1713:05
Conference pass

Robustness in AI

AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1713:05
Conference pass

Fantastic Large Language Models (LLMs) and How to Optimize Them

Large Language Models
Shams Zaman, Senior Director, Global Biometrics & Data Sciences, Bristol-Myers Squibb
Sep 1713:05
Conference pass

Making Digital Transformation a Success: Technology, Strategy and People

Digital Transformation
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Sep 1713:05
Conference pass

Insights from internal and external oncology data toward successful study designs – leveraging AI/NLP

Big Data in Oncology
Harpreet Sahni, Director and Strategic Lead Information Practice, Late Stage Oncology, astrazeneca
Sep 1713:05
Conference pass

Utilizing large-scale biobank-based human circulating proteomics and genetics to enhance novel therapeutic target discovery

Bioinformatics + In Silico R&D
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Sep 1713:05
Conference pass

Real World Evidence in pharmacovigilance

Real World Evidence
William Blumentals, Head of Pharmacoepidemiology, Specialty Care, Sanofi
Sep 1713:05
Conference pass

How to pay for gene therapy

Gene Therapy
Joseph Fuhr, Adjunct Faculty, Johns Hopkins University
Sep 1713:05
Conference pass

How to pay for gene therapy

Gene Therapy
Joseph Fuhr, Adjunct Faculty, Johns Hopkins University
Sep 1713:05
Conference pass

FDA and the evolution of companion diagnostics

Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1714:25
Conference pass

Chair remarks

AI in Drug Discovery and Development
Gregory Fiore, Former CEO, Exacis Biotherapeutics
Sep 1714:25
Conference pass

Chair remarks

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1714:25
Conference pass

Chair remarks

Data Management, Storage and Architecture
Sep 1714:25
Conference pass

Chair remarks

Real World Evidence
Kristy Singletary, Director, L&D Strategy Lead, Enabling Functions, Pfizer
Sep 1714:25
Conference pass

Chair remarks

Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1714:25
Conference pass

Chair remarks

Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1714:30
Conference pass

Multiomics and deep machine learning in IBD patient subtyping

AI in Drug Discovery and Development
Dimitra Chalkia, VP Computational Biology, Athos Therapeutics Inc
Sep 1714:30
Conference pass

Different use cases of Large Language Models for improving clinical trials

Large Language Models
Amir Emadzadeh, Director, Software Engineering, Genentech
Sep 1714:30
Conference pass

Bringing the digital world into a manufacturing facility

Digital Transformation
Britta Stager, Senior Technology Associate, MSAT, GSK
Sep 1714:30
Conference pass

Oncology biobanks: Partners in research for quality patient samples and data

Big Data in Oncology
Dianne Chadwick, Associate Director, Ontario Tumour and Data Repository
Sep 1714:30
Conference pass

Speaker presentation

Data Integration + FAIR
Daniel Kircher, Manager, IT Business Partner, Early Phase Translational Medicine, Otsuka
Sep 1714:30
Conference pass

Neoantigen Cancer Vaccine Delivery

Bioinformatics + In Silico R&D
Don Diamond, Professor, Department Of Hematology And Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Sep 1714:30
Conference pass

Design and AI

Data Management, Storage and Architecture
Sep 1714:30
Conference pass

Creating an environment for psychological safety to drive innovation

Real World Evidence
Kristy Singletary, Director, L&D Strategy Lead, Enabling Functions, Pfizer
Sep 1714:30
Conference pass

New-born Screening in Gene Therapy

Gene Therapy
Tara Britt, President & Founder, Rare Disease Innovations Institute, Inc.
Sep 1714:30
Conference pass

Foundation models in the search for new patients segments and biomarker discovery

Biomarkers and Companion Diagnostics
Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology, AstraZeneca
Sep 1715:10
Conference pass

Leveraging Epidemiology, AI/ ML and RWD to discover new indications

AI in Drug Discovery and Development
Leo Russo, Vice President and Head of Global Medical Epidemiolog, Pfizer
Sep 1715:10
Conference pass

Using LLMs to match patients to clinical trials

Large Language Models
Selvin Soby, Director, informatics Data Analytics & Head of Product, Montefiore Information Technology
Sep 1715:10
Conference pass

Digital transformation is not just digital optimisation. It‘s about people, processes and technology

Digital Transformation
Sep 1715:10
Conference pass

Using Large data bases to improve decision making for planning and end point

Big Data in Oncology
Natasha Sahr, Director of Biostatistics, Larimar Therapeutics
Sep 1715:10
Conference pass

Clinical trial data pipeline

Data Integration + FAIR
Sep 1715:10
Conference pass

Speaker presentation

Bioinformatics + In Silico R&D
Michael Zhou, Head of Bioinformatics, Takeda
Sep 1715:10
Conference pass

Standardizing and Automating Clinical Exploratory Data: Unveiling Challenges, Sustaining Initiatives, and Long-term Solutions

Data Management, Storage and Architecture
Yuan Tian, Associate Director, Clinical Bioinformatics and Exploratory Analytics, gilead
Sep 1715:10
Conference pass

The Responsibility of Patient Inclusion by all stakeholders

Real World Evidence
Dawn Ireland, President & Founder, CDH International
Sep 1715:10
Conference pass

Planning smooth growth from garage space to pre-clinical studies

Gene Therapy
Scott Dooley, Director, Intellectual Capital, Interius Biotherapeutics
Sep 1715:10
Conference pass

Novel ways for biomarkers using LLM’s

Biomarkers and Companion Diagnostics
Ioannis Kagiampakis, Portfolio Data Science Lead, AstraZeneca
Sep 1715:50
Conference pass

Center for Data-Driven Drug Development and Treatment Assessment (DATA): A National Center to Promote AI for Drug Design and Assessment

AI in Drug Discovery and Development
Kayvan Najarian, Director DATA IUCRC, University of Michigan
Sep 1715:50
Conference pass

Implementing GenAI at enterprise scale for life sciences Industry

Large Language Models
Sairam Menon, Engineering Manager, AI product line owner, Global Pharma R&D Tech, Janssen
Sep 1715:50
Conference pass

Digital transformation in Aggregate Reporting

Digital Transformation
Sep 1715:50
Conference pass

Multi model characterization of advanced malignancies

Big Data in Oncology
Sep 1715:50
Conference pass

Pitfalls and Best Practices: Notes from the (research) field

Data Integration + FAIR
Sep 1715:50
Conference pass

Data Frameworks for Target Discovery

Bioinformatics + In Silico R&D
Sep 1715:50
Conference pass

Solving for the rare disease patient diagnostic odyssey: AI/ML

Real World Evidence
Paul Howard, PhD, Senior Director of Public Policy, Amicus Therapeutics
Sep 1715:50
Conference pass

Developing targeted therapeutic delivery devices for ocular gene therapy

Gene Therapy
Justin Creel, Head Targeted Therapeutics Delivery Center, Novartis
Sep 1715:50
Conference pass

Clavulanic acid decreases cocaine craving- treatment for cocaine addiction

Biomarkers and Companion Diagnostics
Mary Morrison, Vice Chair of Research and Professor of Psychiatry, Lewis Katz School of Medicine, Temple University
Sep 1716:40
Conference pass

Chair remarks

AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1716:40
Conference pass

Chair remarks

Large Language Models
Diane Wuest, VP, AI & Analytics Products, Genmab
Sep 1716:40
Conference pass

Chair remarks

Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1716:40
Conference pass

Chair remarks

Big Data in Oncology
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sep 1716:40
Conference pass

Chair remarks

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1716:40
Conference pass

Chair remarks

Bioinformatics + In Silico R&D
Emmanouil Dermitzakis, Vice President and Head of Computational Biology, GSK
Sep 1716:40
Conference pass
Sep 1716:40
Conference pass
Sep 1716:40
Conference pass

Chair remarks

Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1716:40
Conference pass

Chair remarks

Biomarkers and Companion Diagnostics
Akash Jain, Associate Director, Merck
Sep 1716:45
Conference pass

Leveraging AI for Healthcare Delivery & Insights

AI in Drug Discovery and Development
Sep 1716:45
Conference pass

Speaker presentation

Large Language Models
Shams Zaman, Senior Director, Global Biometrics & Data Sciences, Bristol-Myers Squibb
Sep 1716:45
Conference pass

Overcoming data bias for wellbeing

Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1716:45
Conference pass

Clinicogenomic patient level data in drug discovery and translational science

Big Data in Oncology
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sep 1716:45
Conference pass

Capturing data models across R&D opperations at a early biotech level

Data Integration + FAIR
Pavan Patel, Senior Scientist, Interius BioTherapeutics, Inc.
Sep 1716:45
Conference pass

Human genomics in drug discovery

Bioinformatics + In Silico R&D
Emmanouil Dermitzakis, Vice President and Head of Computational Biology, GSK
Sep 1716:45
Conference pass

Global ELN Consolidation and Searchability

Data Management, Storage and Architecture
David Deng, Technology Lead, R&D Technology, Data Sciences Institute, Takeda Pharmaceuticals
Sep 1716:45
Conference pass

Using real world evidence in clinical trial data for indication finding

Real World Evidence
Ziv BarJoseph, Head, R&D Data and Computational Sciences, Sanofi
Sep 1716:45
Conference pass

Navigating the Gene Therapy Commercialization Journey

Gene Therapy
Yaa Bruce, Advisor, SPARK at Stanford
Sep 1716:45
Conference pass

Impact of new regulation of patient selection of clinical trials

Biomarkers and Companion Diagnostics
Sep 1717:25
Conference pass

"promise vs. hype" and how LLMs will become a standard tool used by all scientists to accelerate and even derisk their work

Large Language Models
Moderator: Aaron Mackey, VP, Head of Data & AI/ML, Sonata Therapeutics
Flora Nanda, Director AI/ML, Data, Advanced Analytics, Pfizer
Linn Bieske, MIT Leaders For Global Operations, Harvard John A. Paulson School of Engineering and Applied Sciences
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Abhishek Pandey, Global Lead and Principal Research Scientist, Abbvie
Sep 1717:25
Conference pass

Navigating the Digital Frontier: R&D’s Path Ahead

Digital Transformation
Sep 1717:25
Conference pass

Clinicogenomic patient level data in drug discovery and translational science

Big Data in Oncology
Moderator: Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sunita Badola, Head, Oncology Data Strategy & Partnerships, Takeda Pharmaceuticals
Gaurav Kumar, Associate Director, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1717:25
Conference pass

Demystifying FAIR

Data Integration + FAIR
Moderator: Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Marc Dencker, Director of Enterprise Architecture & Strategy, Vertex Pharmaceuticals
Alex Villalobos, Operations Excellence and Digital Lead, Boehringer Ingelheim
Sudheer Elapavuluru, Principal Agile Coach - Global R&D and Development Strategies, Boehringer Ingelheim
Sep 1717:25
Conference pass

Leveraging new technologies to support bioinformatics in drug discovery

Bioinformatics + In Silico R&D
William Godinez, Senior Principal Data Scientist, Novartis
Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Sep 1717:25
Conference pass

Challenges in global systems implementation and integration

Data Management, Storage and Architecture
Moderator: David Deng, Technology Lead, R&D Technology, Data Sciences Institute, Takeda Pharmaceuticals
Song Yi, Senior Data and AI Platform Engineer, GSK
Justin Ducote, Head, Advanced Analytics R&D, Takeda
Sep 1717:25
Conference pass

How real is real world data for diversity, equity, inclusion and accessibility?

Real World Evidence
Moderator: Leonie Misquitta, Senior Health Scientist, Office Of The National Coordinator For Health Information Technology
Xiaoying Wu, VP, Data Science Solutions, Privacy & Ethics, R&D, Johnson & Johnson Innovation
Neena Nizar, President and Founder, The Jansens Foundation
Donna Sattler, Director, Clinical Data Standards, Bristol Myers Squibb
Dawn Ireland, President & Founder, CDH International
Sep 1717:25
Conference pass

Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations

Gene Therapy
Moderator: Alex Sverdlov, Senior Director of Biostatistics, Novartis
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Donald Milton, Chief Executive Officer, La Jolla Labs
Sep 1717:25
Conference pass

Biomarkers for Neurodegenerative disease and cancers

Biomarkers and Companion Diagnostics
Raluca Predoiu, Companion Diagnostic Strategy Lead, Abbvie
Mary Morrison, Vice Chair of Research and Professor of Psychiatry, Lewis Katz School of Medicine, Temple University

Create your personal agenda –check the favourite icon

Sep 188:50
Conference pass

Introductory remarks

Keynotes
Anna Abiola, Producer, Terrapinn Holdings Ltd
Sep 188:55
Conference pass

Chair remarks

Keynotes
Marcia Rupnow, Vice President, Real World Data and Analytics, GSK
Sep 189:40
Conference pass

Breaking Barriers: Innovations in Pediatric Genetic Disease Diagnosis and Treatment

Keynotes
Wendy Benson, Chief Strategy and Innovation Officer, Rady Children's Institute for Genomic Medicine
Sep 1811:40
Conference pass

Chair remarks

AI in Drug Discovery and Development
Nikolai Makaranka, Director, Manufacturing Analytics, Bristol Myers Squibb
Sep 1811:40
Conference pass

Chair remarks

Large Language Models
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Sep 1811:40
Conference pass

Chair remarks

Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1811:40
Conference pass

Chair remarks

Data Integration + FAIR
Saritha Kuriakose, Senior Director - Data Representation, Novo Nordisk
Sep 1811:40
Conference pass

Chair remarks

Bioinformatics + In Silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1811:40
Conference pass

Chair remarks

Real World Evidence
Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda
Sep 1811:40
Conference pass
Sep 1811:40
Conference pass

Chair remarks

Quantum Integration
Sep 1811:40
Conference pass

Chair remarks

Precision Medicine and Liquid Biopsy
Maha Mehanna, Vice President, Business Development & Portfolio, X-Gen Pharmaceuticals, Inc
Sep 1811:40
Conference pass

Chair remarks

Rare Diseases in Genomics
Catherine Brownstein, Professor, Harvard Medical School
Sep 1811:45
Conference pass

Session Confirmation - BioTechX USA 2024 – 17-18 September – Pennsylvania, Philadelphia

AI in Drug Discovery and Development
Chidinma Ekeh, Global Project Manager, Roche
Sep 1811:45
Conference pass

Integrating large language models in companies

Large Language Models
Kevin Lee, Director of Data Innovation, Karuna
Sep 1811:45
Conference pass

Digital Transformation in the life science industry

Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Viswanath Nittala, IT Product Manager, Development Technology, Takeda Pharmaceuticals, Takeda Pharmaceuticals
Sep 1811:45
Conference pass

FAIR data for gen AI aspirations

Data Integration + FAIR
Saritha Kuriakose, Senior Director - Data Representation, Novo Nordisk
Sep 1811:45
Conference pass

Multi-omics and AI for target identification and validation

Bioinformatics + In Silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1811:45
Conference pass

Embedding real-world evidence into clinical-decision-making across BUPA

Real World Evidence
Lucy Hoppe, Head of Clinical Evidence, Bupa
Sep 1811:45
Conference pass

Unveiling Oncology Insights through Multimodal Data Analytics on AWS

Analytics Platform
Hyunjae Ryan Kim, Associate Director, Gilead Sciences
Sep 1811:45
Conference pass

Reproducibility of Quantum Computing results in Pharmacology

Quantum Integration
Sep 1811:45
Conference pass

How we integrate preclinical and clinical data for dose selection in oncology

Precision Medicine and Liquid Biopsy
Suzette Girgis, Vice President, Head of Global Clinical Pharmacology & Pharmacometrics, Jazz Pharmaceuticals
Sep 1811:45
Conference pass

Rare disease discovery at a tertiary hospital

Rare Diseases in Genomics
Catherine Brownstein, Professor, Harvard Medical School
Sep 1812:05
Conference pass

Use of Real-world data and real world evidence in rare disease

Rare Diseases in Genomics
Karin Hoelzer, Director of Policy and Regulatory Affairs, National Organization for Rare Disorders
Sep 1812:25
Conference pass

Machine learning for phenotypic drug discovery

AI in Drug Discovery and Development
William Godinez, Senior Principal Data Scientist, Novartis
Sep 1812:25
Conference pass

Digitalizing Pfizer Biologics R&D

Digital Transformation
Yuan Lin, Global Biologics Solution Lead, Pfizer
Sep 1812:25
Conference pass

Data Governance isn’t one size fits all

Data Integration + FAIR

Jennifer Lee is a board of directors, investor, venture partner, and SVP of Clinical Operations at Novita Pharmaceuticals. She is an influential biotech executive, driving the transformation of innovative science into life-saving treatments for over two decades. Therapies she’s steered have culminated in $20 billion in value, seven global regulatory approvals, label changes, multiple inspections, and multi-million dollar exits.

Jennifer is a noted STEM advocate and contributes to the field through multiple board and advisory roles and publications.

Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1812:25
Conference pass

Deep Biology as a translational platform for immune-mediated diseases

Bioinformatics + In Silico R&D
Sep 1812:25
Conference pass

Exploiting UK and American collaboration opportunities for Real World Evidence Generation

Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1812:25
Conference pass

Gen AI powering Medical and Patient Safety reviews

Analytics Platform
Sep 1812:25
Conference pass

Quantum technologies for the life sciences

Quantum Integration
Warwick Bowen, Professor, The University of Queensland
Sep 1812:25
Conference pass

Cutting Edge -Omics Research and Early-stage Startups in Precision Medicine

Precision Medicine and Liquid Biopsy
Vaibhav Saini, Sr. Commercialization Manager, Northeastern University
Sep 1812:25
Conference pass

Speaker presentation

Rare Diseases in Genomics
Kathleen Barnes, Professor of Medicine & Epidemiology, University Of Colorado Anschutz Medical Campus
Sep 1813:05
Conference pass

Leveraging AI to enhance the clinical development decision making

AI in Drug Discovery and Development
Zhaoling Meng, AVP, Global Head Clinical Modeling & Evidence Integration, Data and Data Sciences, Sanofi
Sep 1813:05
Conference pass

Domain specific LLM development for enterprise: approaches and challenges

Large Language Models
Zhenwen Shao, Director of Head of Digital Product Development, Johnson & Johnson
Sep 1813:05
Conference pass

How Data Centric Approaches are Transforming the Commercialization Success in the Life Sciences Industry

Digital Transformation
Nuvan Dassanaike, SVP of Marketing and Digital Strategy, Accord Healthcare
Sep 1813:05
Conference pass

Integrated data management systems for driving faster insights for biomarker data

Data Integration + FAIR
Samir Wadhawan, Director Oncology Data Strategy, Analytics, Takeda
Sep 1813:05
Conference pass

Investigation of regulatory genes in a systems biology and machine learning perspective

Bioinformatics + In Silico R&D
Qi Song, Senior Scientist, Bristol Myers Squibb
Sep 1813:05
Conference pass

Clinical Decision Support Systems: Applying Data Science and Machine Learning in Service of Health Equity

Real World Evidence
Sep 1813:05
Conference pass

Development of analytics screens for versatile screening platforms

Analytics Platform
Pavan Patel, Senior Scientist, Interius BioTherapeutics, Inc.
Sep 1813:05
Conference pass
Sep 1813:05
Conference pass

Advancement of digital innovation in autoimmune diseases

Precision Medicine and Liquid Biopsy
Jin Lee, Investor, Oxford angel fund
Sep 1813:05
Conference pass

Defining patient engagement in the age of patient-led drug discovery

Rare Diseases in Genomics
Sep 1814:25
Conference pass
Sep 1814:25
Conference pass

Chair remarks

Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1814:25
Conference pass

Chair remarks

Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1814:25
Conference pass

Chair remarks

Quantum Integration
Wolfgang Losert, Professor of Physics, University of Maryland
Sep 1814:25
Conference pass

Chair remarks

Precision Medicine and Liquid Biopsy
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Sep 1814:25
Conference pass

Chair remarks

Rare Diseases in Genomics
Christina Waters, Chief Executive Officer, RARE Science
Sep 1814:30
Conference pass

AI and Digital platform technologies: Sustaining company growth

AI in Drug Discovery and Development
Sep 1814:30
Conference pass

Research focus for digital products in healthcare

Digital Transformation
Thomas Prangenberg, Head of Product and Design, Boehringer Ingelheim
Sep 1814:30
Conference pass

Federated trial emulations using real-world data for drug repositioning

Data Integration + FAIR
Yong Chen, Professor of Biostatistics, University of Pennsylvania
Sep 1814:30
Conference pass

Democratizing Target discovery and validation through personalized learning journeys

Bioinformatics + In Silico R&D

Breakthroughs in drug discovery depend on bioinformatics and in silico R&ED. Understanding the conclusions and harnessingthem in target discovery and validation rely on digital literacy, often overlooked yet pivotal. Our session will share insights, struggles, and solutions from our journey to create personalized learning journeys in bioinformatics and in silico R&ED within the line of business, integrating digital advancements into the everyday practice of R&ED, locally and globally. The goal is to prepare everyone for genAI employability, harvest digital skills to democratize understanding of bioinformatics and in silico R&ED within the line of business, and seamlessly integrate these practices within a global setting.

Søren Schandorff, Learning Officer, Novo Nordisk
Sep 1814:30
Conference pass

Using real world data to identify meaningful outcomes and endpoints

Real World Evidence
Sep 1814:30
Conference pass

Utility of analytics platforms

Analytics Platform
Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk
Sep 1814:30
Conference pass

Nanocluster Bioactuators, Quantum sensing and actuation

Quantum Integration
Wolfgang Losert, Professor of Physics, University of Maryland
Sep 1814:30
Conference pass

Precision medicine collaboration in the liquid biopsy space: challenges and opportunities

Precision Medicine and Liquid Biopsy
Nicole StJean, Head of Precision Medicine, External Business Strategy, GSK
Sep 1814:30
Conference pass

Redefining regulatory pathways in rare disease with patient advocates

Rare Diseases in Genomics
Mary Leuchars, Senior Director of Rare Disease, Moderna, Inc.
Sep 1814:50
Conference pass

Merging technologies in precision medicine

Precision Medicine and Liquid Biopsy
Nirmit Kumar, Senior Global Medical Affairs Leader, Breast Cancer Diagnostics Strategy, AstraZeneca
Sep 1814:50
Conference pass

Challenges and solutions of patient engagement in N of 1 trials

Rare Diseases in Genomics
Neena Nizar, President and Founder, The Jansens Foundation
Sep 1815:10
Conference pass

Generative AI models for drug discovery

AI in Drug Discovery and Development
Sep 1815:10
Conference pass

Precision medicine in identifying rare diseases in clinical trials

Large Language Models
Guglielmo Iozzia, Associate Director - Machine Learning and AI, MSD
Sep 1815:10
Conference pass

Digital Patient Monitoring

Digital Transformation
Christina Kotsi, Digital Lead, Global Medical Affairs, bayer
Sep 1815:10
Conference pass

A multi-disciplinary approach at SPARC: igniting multi-disciplinary trail blaze for AI enabled drug discovery.

Bioinformatics + In Silico R&D
Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Sep 1815:10
Conference pass

Bridging the health disparity gap with Diverse and Inclusive data collection in clinical trials

Real World Evidence
Donna Sattler, Director, Clinical Data Standards, Bristol Myers Squibb
Sep 1815:10
Conference pass

Developing skills and competencies for modern day analytics for healthcare

Analytics Platform
Veena Swaminathan, Head of Portfolio Analytics - Global R&D, Sanofi
Sep 1815:10
Conference pass

Necrobotics 360: Shaping the Future of Healthcare

Quantum Integration

Revolutionizing patient care: Necrobotics pioneers a healthcare revolution by seamlessly integrating AI and robotics, pushing the boundaries of innovation in patient treatment and diagnostics.

Precision in healthcare procedures: Exploring the dynamic synergy between AI and robotics, enhancing precision in diagnostics, surgeries and overall healthcare delivery for a more effective patient experience.

Navigating ethical considerations: Delving into the ethical considerations surrounding AI-driven necrobotics, emphasizing responsible deployment through the establishment of robust regulatory frameworks.

Collective vision for tomorrow: Necrobotics serves as a collaborative platform, bringing together experts and stakeholders to shape a future where AI and robotics harmonize to redefine and elevate the healthcare landscape.

Sep 1815:10
Conference pass

AI Driven Precision Medicine

Precision Medicine and Liquid Biopsy
Shameer Khader, Global Head, Data Science and Precision Medicine, Sanofi
Sep 1815:10
Conference pass

Revolutionizing Healthcare: Unleashing Innovation in Academic Institution

Rare Diseases in Genomics
Sohela Shah, Program Director, Catalyst Program and Invent Fund, UCSF Innovation Venture
Sep 1815:30
Conference pass

Bioinformatics and AI for precision medicine

Bioinformatics + In Silico R&D
Han Chang, Senior Director, Head of Late Stage Oncology, Translational Bioinformatics, Bristol-Myers Squibb
Sep 1815:30
Conference pass

Real World Evidence in Biosimilar Clinical Development

Real World Evidence
Liyi Cen, Group Head of Biostatistics, Sandoz
Sep 1815:30
Conference pass

Enabling Precision Medicine in Inflammatory Bowel Disease with IBD Plexus

Precision Medicine and Liquid Biopsy
Sep 1815:30
Conference pass

Precision genetic therapies for rare diseases

Rare Diseases in Genomics
Nick Lench, Executive Director, Nucleic Acid Therapy Accelerator (NATA)
Sep 1815:50
Conference pass

Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

AI in Drug Discovery and Development
Sep 1815:50
Conference pass

Generative AI: Five stages of grief

Large Language Models
Marco Andre, Global Head of Marketing Excellence, Novartis
Sep 1815:50
Conference pass

How to navigate volatility within your digital journey

Digital Transformation
Sudheer Elapavuluru, Principal Agile Coach - Global R&D and Development Strategies, Boehringer Ingelheim
Sep 1815:50
Conference pass

Med.ai-ORBIT: Harnessing Multimodal Data Analytics in Clinical Research to Advance Precision Medicine

Data Integration + FAIR
Alex Li, Director, R&D Data Science, Johnson & Johnson
Sep 1815:50
Conference pass

Multi-omics

Bioinformatics + In Silico R&D
Gaurav Kumar, Associate Director, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1815:50
Conference pass

Communicating to Senior Execs and Impacting Strategy to Drive Key Business Decisions

Real World Evidence
Alexa DeVita, Associate Director of Competitive Intelligence and Strategy, Vir Biotechnology, Inc.
Sep 1815:50
Conference pass

AI-powered clinical decision support system for heart surgery patients

Precision Medicine and Liquid Biopsy
Sep 1815:50
Conference pass

HNRNPs - An Emerging Class of Rare Neurodevelopmental Disorders

Rare Diseases in Genomics
Christopher Ricupero, Associate Research Scientist, Columbia University Irving Medical Center
Sep 1816:40
Conference pass

Chair remarks

AI in Drug Discovery and Development
Xiaoying Wu, VP, Data Science Solutions, Privacy & Ethics, R&D, Johnson & Johnson Innovation
Sep 1816:40
Conference pass
Sep 1816:40
Conference pass

Chair remarks

Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1816:40
Conference pass

Chair remarks

Data Integration + FAIR
Daniel Lane, Senior Director, IPS Translational Epidemiology, Bristol Myers Squibb
Sep 1816:40
Conference pass

Chair remarks

Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1816:40
Conference pass
Sep 1816:40
Conference pass

Chair remarks

Quantum Integration
Sep 1816:40
Conference pass

Chair remarks

Rare Diseases in Genomics
Anna Capria, Outreach Coordinator and Bioinformatic Analyst, J. Craig Venter Institute
Sep 1816:45
Conference pass

Using AI to optimize multiple properties of antibodies

AI in Drug Discovery and Development
Tzvika Hartman, SVP Computation, Biolojic Design
Sep 1816:45
Conference pass

Shaping the regulatory function to support product digital transformation

Digital Transformation
David Morra, Director, Regulatory Digital Health, Merck
Sep 1816:45
Conference pass

Developing an integrated real word data ecosystem to support accelerating research and development programs

Data Integration + FAIR
Daniel Lane, Senior Director, IPS Translational Epidemiology, Bristol Myers Squibb
Sep 1816:45
Conference pass

Harnessing the muscarinic system: from bench side to clinic

Bioinformatics + In Silico R&D
Samantha Yohn, Associate Director, Global Scientific communications, engagement and outreach, Karuna Therapeutics
Sep 1816:45
Conference pass

Developing the next BioTech Workforce: The impact of Belonging in K-12 STEM Education as a Tool to Gain and Sustain Interest in STEM

Real World Evidence
Ashley huderson, STEM and CS Equity Advisor, U.S. Department of Education
Sep 1816:45
Conference pass

Liquid Biopsy in solid tumours – are we there yet

Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, Abbvie
Sep 1816:45
Conference pass

Rare disease advocacy

Rare Diseases in Genomics
Anna Capria, Outreach Coordinator and Bioinformatic Analyst, J. Craig Venter Institute
Sep 1817:05
Conference pass

Closing keynote Panel

Keynotes
Moderator: Christina Waters, Chief Executive Officer, RARE Science
Michele Colucci, Founder, Chief Executive Officer, Digital DX Ventures
Sarah Odeh, National President, Women In Bio
Victoria Gamerman, Head of Digital Transformation Center of Excellence, Boehringer Ingelheim
last published: 07/May/24 17:35 GMT

Get involved at BioTechX USA

 

 

TO SPONSOR


Myra Christodoulou

myra.christodoulou@terrapinn.com

 

Joshua Kennedy
joshua.kennedy@terrapinn.com

 

TO SPEAK


Anna Abiola
anna.abiola@terrapinn.com

 

MARKETING OPPORTUNITIES


Karen Duncan

karen.duncan@terrapinn.com